FDA To Join The 'Real World' Under PDUFA VI

Regulators pledge to explore the use of real-world evidence, strengthen the patient's voice in drug review, and boost the agency's postmarketing surveillance abilities as part of sixth round of user fee program with industry.

PDUFA VI letter

FDA has decided to join the real world next year – or at least, explore it, in terms of what type of data it will consider from innovator drug makers.

More from Product Reviews

More from Pink Sheet